スポンサーリンク
Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences | 論文
- Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population
- A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis
- Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis
- A case of cold agglutinin disease in the course of treatment for polymyalgia rheumatica
- Cutaneous vasculitis induced by TNF inhibitors : a report of three cases
- Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
- Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables
- Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine
- Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.
- Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1^*shared epitope-negative rheuma
- Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor
- In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline
- Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab : comparison with the remission by the clinical disease activity index
- Successful treatment of a patient with IgG4-related disease with a paravertebral mass lesion
- Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines
- Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows and excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors
- A case of Sjogren syndrome with pulmonary amyloidosis complicating microscopic polyangiitis
- A patient with systemic lupus erythematosus who developed massive small intestinal hemorrhaging during treatment for chronic lupus peritonitis
- Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration
- A case of Sjogren's syndrome presenting as trigeminal nerve palsy